At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 14 enrolled
Drug / intervention
TAK-788drug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase 1, Randomized, 2-Period, 2-Sequence, Crossover Study to Evaluate the Effect of High-Fat Meal on TAK-788 Pharmacokinetics in Healthy Adult Subjects
In Brief
A Phase 1 clinical trial evaluating TAK-788 for Healthy Volunteers. Completed, enrolled 14 participants across 1 site.
Detailed Summary
The purpose of this study is to characterize the effect of a high-fat meal on the PK of TAK-788 administered in healthy participants.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy Volunteers
CountriesUnited States
Collaborators--
Timeline
Phase 1CompletedFinished
202120222023202420252026
First PostedJun 2020
Enrollment StartJul 2020
Primary CompletionAug 2020
TodayJul 2026
First PostedJun 22, 2020
Enrollment StartJul 1, 2020
Primary CompletionAug 10, 2020
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 6.0 years ago
Interventions
TAK-788drug
TAK-788 Capsule.